Methods for manufacturing genetically modified immune-active cells

TW202639845APending Publication Date: 2026-10-01NOILE IMMUNE BIOTECH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114147077
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2025-10-07
Filing Date
2025-12-02
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078632_001
    Figure TWG2TA001078632_001
  • Figure TWG2TA001078632_002
    Figure TWG2TA001078632_002
  • Figure TWG2TA001078632_003
    Figure TWG2TA001078632_003
Patent Text Reader

Abstract

This invention provides a novel method for manufacturing immunologically active cells transduced using a retroviral vector. The method for manufacturing genetically modified immunologically active cells includes a transduction step of transducing immunologically active cells using a retroviral vector, and after the transduction step, it substantially does not include an amplification culture step, or includes an amplification culture step of no more than 24 hours.
Need to check novelty before this filing date? Find Prior Art